| US 7,524,837 B2 | ||
| Benzotriazapinone salts and methods for using same | ||
| Ahmed F. Abdel-Magid, Ambler, Pa. (US); and Judith H. Cohen, North Wales, Pa. (US) | ||
| Assigned to Janssen Pharmaceutica N.V., Beerse (Belgium) | ||
| Filed on Apr. 27, 2004, as Appl. No. 10/833,232. | ||
| Claims priority of provisional application 60/469659, filed on May 12, 2003. | ||
| Prior Publication US 2005/0026911 A1, Feb. 03, 2005 | ||
| Int. Cl. C07D 401/04 (2006.01) | ||
| U.S. Cl. 514—183 [540/501] | 15 Claims |
1. A pharmaceutically acceptable choline salt of a compound of formula (I)
![]() W is N or N+—O−;
R1 and R5 are independently H, C1 to C6 alkyl, (C1 to C6 alkyl)oxy, mercapto, (C1 to C6 alkyl)mercapto, carboxy, carboxy(C1 to C6 alkyl), formyl, (C1 to C6 alkyl)carbonyl, (C1 to C6 alkyl)oxycarbonyl, (C1 to C6 alkyl)carbonyloxy, nitro, trihalomethyl, hydroxy, hydroxy(C1 to C6 alkyl), amino, (C1 to C6 alkyl)amino, di(C1 to C6 alkyl)amino, aminocarbonyl, halo, halo(C1 to C6 alkyl), aminosulfonyl, (C1 to C6 alkyl)sulfonylamino, (C1 to C6 alkyl)aminocarbonyl, di(C1 to C6 alkyl)aminocarbonyl, [N-Z](C1 to C6 alkyl)carbonylamino, formyloxy, formamido, (C1 to C6 alkyl)aminosulfonyl, di(C1 to C6 alkyl)aminosulfonyl, [N-Z](C1 to C6 alkyl)sulfonylamino or cyano; or R1 and R5 together form a methylenedioxy group;
R2 is H or a C1 to C18 alkyl, alkenyl, alkynyl, cycloalkyl, polycycloalkyl, cycloalkenyl, or aryl group, or a combination thereof, optionally substituted
with 1, 2, or 3 -L-Q2 groups up to three C atoms of each alkyl, alkenyl, alkynyl, cycloalkyl, polycycloalkyl, cycloalkenyl, or aryl group may optionally
be replaced by N, O and/or S atoms;
R3 is —(CR11R12)m—X—(CR13R14)p—R9;
m is 0, 1, 2, 3 or 4;
p is 0, 1 or 2;
X is a bond, —CR15═CR16—, —C≡C—, C(O)NH, NHC(O), C(O)NMe, NMeC(O), C(O)O, NHC(O)NH, NHC(O)O, OC(O)NH, NH, O, CO, SO2, SO2NH, C(O)NHNH,
![]() R9 is H; C1 to C6 alkyl; or phenyl, naphthyl, pyridyl, benzimidazolyl, indazolyl, quinolinyl, isoquinolinyl, tetrahydroisoquinolinyl, indolinyl,
isoindolinyl, indolyl, isoindolyl or 2-pyridonyl substituted with
-L-Q
wherein:
L is a bond, or a group of the formula —(CR17R18)v—Y—(CR17R18)w, wherein v and w are independently 0, 1, 2 or 3, and Y is a bond, —CR15═CR16—, phenyl, furanyl, thiophenyl, pyrrolyl, thiazolyl, imidazolyl, oxazolyl, isoxazolyl, pyrazolyl, isoxazolonyl, piperazinyl,
piperidinyl, morpholinyl, pyrrolidinyl, isothiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, pyridyl or pyridazyl; and
Q is 5-oxo-2,5-dihydro[1,2,4]oxadiazolyl;
Q2 is H, (C1 to C6 alkyl)oxy, [N-Z](C1 to C6 alkyl)oxy(C1 to C6 alkyl)amino, mercapto, (C1 to C6 alkyl)mercapto, carboxy(C1 to C6 alkyl)thiol, carboxy, carboxy(C1 to C6 alkyl), carboxy(C1 to C6 alkenyl), [N-Z]carboxy(C1 to C6 alkyl)amino, carboxy(C1 to C6 alkyl)oxy, formyl, (C1 to C6 alkyl)carbonyl, (C1 to C6 cycloalkyl)carbonyl, (C1 to C6 alkyl)oxycarbonyl, (C1 to C6 alkyl)carbonyloxy, nitro, trihalomethyl, hydroxy, amino, [N-Z](C1 to C6 alkyl)amino, aminocarbonyl, (C1 to C6 alkyl)aminocarbonyl, di(C1 to C6 alkyl)aminocarbonyl, [N-Z](C1 to C6 alkyl)carbonylamino, C5 to C8 cycloalkyl, [N-Z](C1 to C6 alkyl)carbonyl(C1 to C6 alkyl)amino, halo, halo(C1 to C6 alkyl), sulfamoyl, [N-Z](C1 to C6 alkyl)sulfonylamino, (C1 to C6 alkyl)sulfonylaminocarbonyl, carboxy(C1 to C6 alkyl)sulfonyl, carboxy(C1 to C6 alkyl)sulfinyl, tetrazolyl, [N-Z]tetrazolylamino, cyano, amidino, amidinothio, SO3H, formyloxy, formamido, C3 to C8 cycloalkyl, (C1 to C6 alkyl)sulphamoyl, di(C1 to C6 alkyl)sulphamoyl, (C1 to C6 alkyl)carbonylaminosulfonyl, 5-oxo-2,5-dihydro[1,2,4]oxadiazolyl, carboxy(C1 to C6 alkyl)carbonylamino, tetrazolyl(C1 to C6 alkyl)thio, [N-Z]tetrazolyl(C1 to C6 alkyl)amino, 5-oxo-2,5-dihydro[1,2,4]thiadiazolyl, 5-oxo-1,2-dihydro[1,2,4]triazolyl, [N-Z](C1 to C6 alkyl)amino(C1 to C6 alkyl)amino, or a group of the formula
![]() P is O, S or NR19;
Z is H, C1 to C6 alkyl, t-butoxycarbonyl, acetyl, benzoyl or benzyl;
R4 is H or a C1 to C18 alkyl, alkenyl, alkynyl, cycloalkyl, polycycloalkyl, cycloalkenyl, or aryl group, or a combination thereof, optionally substituted
with 1, 2, or 3 -L-Q2 groups wherein up to three C atoms of each alkyl, alkenyl, alkynyl, cycloalkyl, polycycloalkyl, cycloalkenyl, or aryl group
may optionally be replaced by N, O and/or S atoms;
R11, R12, R13, R14, R15, R17, R18 and R19 are independently H or C1 to C3 alkyl; and
R16 is H, C1 to C3 alkyl, or acetylamino.
|